Splitting of Pi and other 31P NMR anomalies of skeletal muscle metabolites in canine muscular dystrophy

Current Status of Pharmaceutical and Genetic Therapeutic Approaches to Treat DMD

(2011) Christophe Pichavant et al.   MOLECULAR THERAPY

Comparison of in vivo postexercise phosphocreatine recovery and resting ATP synthesis flux for the assessment of skeletal muscle mitochondrial function

(2010) N. M. A. van den Broek et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Bio-energetic impairment in human calf muscle in thyroid disorders: a 31P MRS study

(2010) Subash Khushu et al.   MAGNETIC RESONANCE IMAGING

Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study

(2010) Bidisha Banerjee et al.   MAGNETIC RESONANCE IMAGING

In vivo31P MRS detection of an alkaline inorganic phosphate pool with short T1 in human resting skeletal muscle

(2010) H. E. Kan et al.   NMR IN BIOMEDICINE

Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy

(2009) M. Wehling-Henricks et al.   HUMAN MOLECULAR GENETICS

Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package

(2009) D Stefan et al.   MEASUREMENT SCIENCE and TECHNOLOGY

Mammalian animal models for Duchenne muscular dystrophy

(2009) Raffaella Willmann et al.   NEUROMUSCULAR DISORDERS

The interpretation of abnormal 31P magnetic resonance saturation transfer measurements of Pi/ATP exchange in insulin-resistant skeletal muscle

(2008) Graham J. Kemp   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM